Logo image of NPK

NATIONAL PRESTO INDS INC (NPK) Stock Fundamental Analysis

NYSE:NPK - US6372151042 - Common Stock

108.53 USD
-0.24 (-0.22%)
Last: 9/5/2025, 2:00:43 PM
Fundamental Rating

5

NPK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 69 industry peers in the Aerospace & Defense industry. NPK has only an average score on both its financial health and profitability. NPK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year NPK was profitable.
NPK had a negative operating cash flow in the past year.
In the past 5 years NPK has always been profitable.
Of the past 5 years NPK 4 years had a positive operating cash flow.
NPK Yearly Net Income VS EBIT VS OCF VS FCFNPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

NPK has a Return On Assets of 8.81%. This is amongst the best in the industry. NPK outperforms 94.20% of its industry peers.
The Return On Equity of NPK (11.11%) is better than 75.36% of its industry peers.
NPK's Return On Invested Capital of 10.35% is amongst the best of the industry. NPK outperforms 86.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NPK is in line with the industry average of 8.22%.
The last Return On Invested Capital (10.35%) for NPK is above the 3 year average (7.92%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.81%
ROE 11.11%
ROIC 10.35%
ROA(3y)7.34%
ROA(5y)7.8%
ROE(3y)8.97%
ROE(5y)9.33%
ROIC(3y)7.92%
ROIC(5y)8.51%
NPK Yearly ROA, ROE, ROICNPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of NPK (9.23%) is better than 76.81% of its industry peers.
NPK's Profit Margin has declined in the last couple of years.
The Operating Margin of NPK (11.19%) is better than 73.91% of its industry peers.
NPK's Operating Margin has declined in the last couple of years.
The Gross Margin of NPK (19.23%) is worse than 66.67% of its industry peers.
NPK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.19%
PM (TTM) 9.23%
GM 19.23%
OM growth 3Y11.37%
OM growth 5Y-4.99%
PM growth 3Y13.92%
PM growth 5Y-4.83%
GM growth 3Y3.79%
GM growth 5Y-2.78%
NPK Yearly Profit, Operating, Gross MarginsNPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NPK is creating some value.
NPK has more shares outstanding than it did 1 year ago.
NPK has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NPK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NPK Yearly Shares OutstandingNPK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
NPK Yearly Total Debt VS Total AssetsNPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NPK has an Altman-Z score of 7.85. This indicates that NPK is financially healthy and has little risk of bankruptcy at the moment.
NPK has a Altman-Z score of 7.85. This is in the better half of the industry: NPK outperforms 79.71% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that NPK is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.03, NPK belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 7.85
ROIC/WACC1.07
WACC9.71%
NPK Yearly LT Debt VS Equity VS FCFNPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.21 indicates that NPK has no problem at all paying its short term obligations.
NPK has a Current ratio of 4.21. This is amongst the best in the industry. NPK outperforms 88.41% of its industry peers.
NPK has a Quick Ratio of 4.21. This is a bad value and indicates that NPK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.76, NPK is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 4.21
Quick Ratio 0.76
NPK Yearly Current Assets VS Current LiabilitesNPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

NPK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.24%, which is quite impressive.
The Earnings Per Share has been decreasing by -0.69% on average over the past years.
NPK shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.28%.
Measured over the past years, NPK shows a small growth in Revenue. The Revenue has been growing by 4.70% on average per year.
EPS 1Y (TTM)26.24%
EPS 3Y17.02%
EPS 5Y-0.69%
EPS Q2Q%-15.45%
Revenue 1Y (TTM)31.28%
Revenue growth 3Y2.95%
Revenue growth 5Y4.7%
Sales Q2Q%41.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPK Yearly Revenue VS EstimatesNPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.62, NPK is valued on the expensive side.
92.75% of the companies in the same industry are more expensive than NPK, based on the Price/Earnings ratio.
NPK is valuated rather cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.62
Fwd PE N/A
NPK Price Earnings VS Forward Price EarningsNPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

91.30% of the companies in the same industry are more expensive than NPK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.93
NPK Per share dataNPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The decent profitability rating of NPK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

NPK has a yearly dividend return of 0.94%, which is pretty low.
Compared to an average industry Dividend Yield of 1.64, NPK pays a better dividend. On top of this NPK pays more dividend than 84.06% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, NPK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

The dividend of NPK decreases each year by -5.57%.
NPK has been paying a dividend for at least 10 years, so it has a reliable track record.
NPK has decreased its dividend recently.
Dividend Growth(5Y)-5.57%
Div Incr Years1
Div Non Decr Years1
NPK Yearly Dividends per shareNPK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

17.18% of the earnings are spent on dividend by NPK. This is a low number and sustainable payout ratio.
The Dividend Rate of NPK has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP17.18%
EPS Next 2YN/A
EPS Next 3YN/A
NPK Yearly Income VS Free CF VS DividendNPK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M
NPK Dividend Payout.NPK Dividend Payout, showing the Payout Ratio.NPK Dividend Payout.PayoutRetained Earnings

NATIONAL PRESTO INDS INC

NYSE:NPK (9/5/2025, 2:00:43 PM)

108.53

-0.24 (-0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-25 2025-07-25
Earnings (Next)10-23 2025-10-23
Inst Owners58.66%
Inst Owner Change0.77%
Ins Owners27.97%
Ins Owner Change-0.08%
Market Cap775.99M
Analysts0
Price TargetN/A
Short Float %2.93%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Yearly Dividend4.51
Dividend Growth(5Y)-5.57%
DP17.18%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-04 2025-03-04 (1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.62
Fwd PE N/A
P/S 1.72
P/FCF N/A
P/OCF N/A
P/B 2.07
P/tB 2.21
EV/EBITDA 13.93
EPS(TTM)5.83
EY5.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.76
FCFYN/A
OCF(TTM)-3.29
OCFYN/A
SpS63.02
BVpS52.32
TBVpS49.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.81%
ROE 11.11%
ROCE 13.1%
ROIC 10.35%
ROICexc 10.48%
ROICexgc 11.11%
OM 11.19%
PM (TTM) 9.23%
GM 19.23%
FCFM N/A
ROA(3y)7.34%
ROA(5y)7.8%
ROE(3y)8.97%
ROE(5y)9.33%
ROIC(3y)7.92%
ROIC(5y)8.51%
ROICexc(3y)10.04%
ROICexc(5y)12.33%
ROICexgc(3y)10.99%
ROICexgc(5y)13.46%
ROCE(3y)9.7%
ROCE(5y)10.42%
ROICexcg growth 3Y-2.43%
ROICexcg growth 5Y-10.68%
ROICexc growth 3Y-1.9%
ROICexc growth 5Y-10.27%
OM growth 3Y11.37%
OM growth 5Y-4.99%
PM growth 3Y13.92%
PM growth 5Y-4.83%
GM growth 3Y3.79%
GM growth 5Y-2.78%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.23
Cap/Depr 662.22%
Cap/Sales 7.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.21
Quick Ratio 0.76
Altman-Z 7.85
F-Score5
WACC9.71%
ROIC/WACC1.07
Cap/Depr(3y)70.21%
Cap/Depr(5y)78.92%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.24%
EPS 3Y17.02%
EPS 5Y-0.69%
EPS Q2Q%-15.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.28%
Revenue growth 3Y2.95%
Revenue growth 5Y4.7%
Sales Q2Q%41.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.7%
EBIT growth 3Y14.65%
EBIT growth 5Y-0.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-231.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-153.68%
OCF growth 3YN/A
OCF growth 5YN/A